WELCOME TO
Specialist Communications for Life Sciences
Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value and generate interest from commercial leads, investors and partners.
EVENTS
-
Investival Showcase USA
Tue March 10 2026 -
Date
Mon May 11 2026
Location
-
BIA – Advanced Therapies 2026 Congress
Tue March 17 2026 - Date
Wed March 18 2026 Location
-
BIO Europe Spring
Mon March 23 2026 - Date
Wed March 25 2026 Location
-
Analytica
Tue March 24 2026 - Date
Fri March 27 2026 Location
VALANX Biotech secures €3 million to advance LIV-1 ADC for metastatic triple-negative breast cancer
Foundation Fournier-Majoie and FUJIFILM Corporation join existing VC and angel investors including xista science ventures, tecnet equity and SOSV Financing advances VLX-ADC-001, a LIV-1 targeting ADC, with candidate nomination planned [...]
Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer
Investment led by T&J Meyer Family Foundation, joined by Varia Ventures, NW Angel Fund and other non-institutional investors Financing advances Combat’s HIVEC® HEAT FDA registration trial to change standard of [...]
PINCH Announces Two Major New Contract Wins as Business Growth Continues Into 2026
London, UK, 09 March 2026: PINCH is proud to announce two significant new contract wins, marking an exciting start to the year and reinforcing the company’s continued growth across workplace [...]